← Browse by Condition
Medical Condition

diffuse astrocytoma idh mutant

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06047379 Phase 1, Phase 2
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
View Trial →